| Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants (NCT00386035) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-01-01 |
| Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens (NCT02191319) | Boehringer Ingelheim | 2002-01-01 |
| Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression (NCT00125814) | French National Agency for Research on AIDS and Viral Hepatitis | 2001-12-01 |
| Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART) (NCT00122551) | French National Agency for Research on AIDS and Viral Hepatitis | 2001-12-01 |
| Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS (NCT00079560) | National Institute on Drug Abuse (NIDA) | 2001-12-01 |
| Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV (NCT00035932) | Bristol-Myers Squibb | 2001-11-01 |
| Garlic in Hyperlipidemia Caused by HAART (NCT00029250) | National Center for Complementary and Integrative Health (NCCIH) | 2001-11-01 |
| Prospective Cohort of HIV/HBV-coinfected Patients in Europe (NCT04984772) | Insel Gruppe AG, University Hospital Bern | 2001-10-02 |
| Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients (NCT00274001) | Boehringer Ingelheim | 2001-09-01 |
| Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People (NCT00052195) | Dartmouth-Hitchcock Medical Center | 2001-09-01 |
| Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes (NCT00440206) | Ottawa Hospital Research Institute | 2001-09-01 |
| Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents (NCT00640653) | University of Pennsylvania | 2001-09-01 |
| Quality of Life in Children With HIV Infection (NCT00075153) | University of Medicine and Dentistry of New Jersey | 2001-09-01 |
| Zidovudine Levels in HIV Infected Patients Being Treated for HCV (NCT00059358) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-09-01 |
| A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor (NCT00028067) | Bristol-Myers Squibb | 2001-08-01 |
| Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs (NCT00016718) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-08-01 |
| T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents (NCT00022763) | Hoffmann-La Roche | 2001-08-01 |
| Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection (NCT00023153) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-08-01 |
| TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains (NCT00964327) | Tibotec Pharmaceuticals, Ireland | 2001-08-01 |
| Effects of Creatine and Resistance Exercise Training in People With HIV Infection (NCT00484627) | National Center for Complementary and Integrative Health (NCCIH) | 2001-08-01 |
| Pravastatin for Hyperlipidaemia in HIV. (NCT00227500) | Kirby Institute | 2001-07-01 |
| The Intervention With Microfinance for AIDS and Gender Equity (IMAGE) Study (NCT00242957) | London School of Hygiene and Tropical Medicine | 2001-06-01 |
| Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand (NCT00213057) | Population Council | 2001-06-01 |
| Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients (NCT00018031) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-06-01 |
| Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women (NCT00016601) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-06-01 |
| Zinc Therapy in HIV Infected Individuals Who Abuse Drugs (NCT00149552) | Florida International University | 2001-06-01 |
| Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs (NCT00017771) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-06-01 |
| Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive Patients (NCT02181946) | Boehringer Ingelheim | 2001-05-01 |
| Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs (NCT00016588) | Gilead Sciences | 2001-05-01 |
| Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure (NCT00025727) | GlaxoSmithKline | 2001-05-01 |
| Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2 (NCT00050726) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-05-01 |
| Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women (NCT00271960) | Yale University | 2001-04-01 |
| Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART (NCT00196612) | ANRS, Emerging Infectious Diseases | 2001-04-01 |
| Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People (NCT00053430) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-04-01 |
| Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor (NCT00038519) | Abbott | 2001-04-01 |
| Transfusion Infections Pediatric Prospective Study (TRIPPS) (NCT00029406) | Naomi Luban | 2001-04-01 |
| Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects (NCT00146328) | Boehringer Ingelheim | 2001-04-01 |
| Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART (NCT00038532) | Abbott | 2001-04-01 |
| Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers (NCT00005762) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-03-01 |
| Botswana Diarrheal Diseases Study (NCT00197652) | Harvard School of Public Health (HSPH) | 2001-03-01 |
| Botswana Pediatric Respiratory Disease and Bloodstream Infection Study (NCT00197691) | Harvard School of Public Health (HSPH) | 2001-03-01 |
| Pediatric Expanded Access Program-Oral Solution (0831-908) (NCT00543530) | Merck Sharp & Dohme LLC | 2001-03-01 |
| Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations (NCT00011089) | Gilead Sciences | 2001-02-01 |
| Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s) (NCT00028301) | Bristol-Myers Squibb | 2001-02-01 |
| A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine (NCT00013897) | Bristol-Myers Squibb | 2001-02-01 |
| Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV (NCT00011011) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-02-01 |
| Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV (NCT00074399) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-02-01 |
| Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects (NCT02251223) | Boehringer Ingelheim | 2001-02-01 |
| Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00011895) | GlaxoSmithKline | 2001-02-01 |
| Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand (NCT00398684) | Institut de Recherche pour le Developpement | 2001-01-01 |
| An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection (NCT01902615) | Hoffmann-La Roche | 2001-01-01 |
| Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) (NCT00116298) | Bristol-Myers Squibb | 2001-01-01 |
| Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy (NCT00338767) | Massachusetts General Hospital | 2001-01-01 |
| CSP #512 - Options in Management With Anti-Retrovirals (NCT00050089) | US Department of Veterans Affairs | 2001-01-01 |
| Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy (NCT00122655) | French National Agency for Research on AIDS and Viral Hepatitis | 2001-01-01 |
| A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED) (NCT00541463) | Merck Sharp & Dohme LLC | 2001-01-01 |
| Effects of Storage on Lactate in Blood Samples (NCT00011050) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-01-01 |
| Distant Healing for HIV/AIDS (NCT00079534) | National Center for Complementary and Integrative Health (NCCIH) | 2000-12-01 |
| Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs (NCT00009061) | Glaxo Wellcome | 2000-11-01 |
| Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-infected Patients in Virological Failure. (NCT00196625) | ANRS, Emerging Infectious Diseases | 2000-11-01 |
| HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV Drugs (NCT00007488) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| Safer Choices 2 - HIV, STD, & Pregnancy Prevention Program (NCT00223314) | The University of Texas Health Science Center, Houston | 2000-11-01 |
| Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients (NCT00058734) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) (NCT00008463) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women (NCT00006444) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy (NCT00006190) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-11-01 |
| Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy (NCT00008554) | Glaxo Wellcome | 2000-11-01 |
| Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents (NCT00006604) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-11-01 |
| A Study of HIV-Disease Development in Aging (NCT00006144) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-10-01 |
| Dehydroepiandrosterone Effects on HIV-1 Replication (NCT00065104) | National Center for Complementary and Integrative Health (NCCIH) | 2000-10-01 |
| Supportive Therapy for Adherence to ART(STAART) (NCT00212940) | Ottawa Hospital Research Institute | 2000-10-01 |
| A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors (NCT00038636) | Abbott | 2000-09-01 |
| Reducing HIV & Domestic Violence Risk in Women Offenders (NCT00289939) | Multnomah County Health Department | 2000-09-01 |
| Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users (NCT00228007) | Butler Hospital | 2000-09-01 |
| Immune and Viral Outcomes of HIV-1 Therapy Interruption (NCT00051818) | The Wistar Institute | 2000-09-01 |
| Alternative Stress Management Approaches in HIV Disease (NCT00029237) | National Center for Complementary and Integrative Health (NCCIH) | 2000-09-01 |
| Effectiveness of a Telephone Intervention Program in Improving Depression, Coping, and Family Functioning in HIV-Infected Individuals and Caregivers (NCT00183781) | Butler Hospital | 2000-09-01 |
| Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma (NCT00006171) | National Cancer Institute (NCI) | 2000-08-07 |
| Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir (NCT00006326) | Agouron Pharmaceuticals | 2000-08-01 |
| Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV (NCT00006145) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-08-01 |
| Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs (NCT00006397) | PPD Development, LP | 2000-08-01 |
| A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs (NCT00006208) | Triangle Pharmaceuticals | 2000-08-01 |
| Viral and Host Factors in the Transmission and Pathogenesis of HIV (NCT00219947) | Rockefeller University | 2000-07-01 |
| Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients (NCT00038220) | Abbott | 2000-07-01 |
| Immune Function of Infants With HIV (NCT00073229) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-07-01 |
| The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children (NCT00006064) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs (NCT00006209) | Aaron Diamond AIDS Research Center | 2000-06-01 |
| Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults (NCT00331448) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients (NCT00005918) | Bristol-Myers Squibb | 2000-06-01 |
| A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients (NCT00005764) | Glaxo Wellcome | 2000-05-01 |
| Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance (NCT00187551) | University of California, San Francisco | 2000-05-01 |
| The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00005120) | Sarawak MediChem Pharmaceuticals | 2000-04-01 |
| A Test of Behavioral Intervention for Women at High Risk for HIV Infection (NCT00006440) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-03-01 |
| Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz. (NCT00158821) | Gilead Sciences | 2000-03-01 |
| Safety and Effectiveness of PEG-Intron in HIV-Infected Patients (NCT00005012) | Schering-Plough | 2000-03-01 |
| An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy (NCT00004978) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-03-01 |
| SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era (NCT00187512) | University of California, San Francisco | 2000-03-01 |
| Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients (NCT00004986) | Romark Laboratories L.C. | 2000-02-01 |
| The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV (NCT00004735) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-02-01 |
| TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB (NCT00023400) | Centers for Disease Control and Prevention | 2000-02-01 |